New hires and promotions in the biopharma and med-tech industries, including: Akari, Impedimed, Insitro, Juvenescence, Kymera, Quest, Soleno, Xspray.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Carla, Johnson & Johnson, Mevion, Opus, Pfizer, Polaroid, Scopbio, Siren, Vanda, Viatris, Xenocor.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alchemedicine, Antengene, Asahi Kasei, Ensysce, George, Helsinn, Invirtuobabs, Junshi, Kdventures, Lifeward, Novakand, Novartis, Orient, Ovation, Precisionlife, Skelable, SVF.

Clinical updates for biopharma and med tech, including data readouts and publications: Edesa, Formycon, Immunexpress,Tempest, Tiziana, Viiv.

Biopharma and med-tech companies raising money in public or private financings, including: Abram, Bicara, Breezebio, Octapharma, Respiree, Trinity, Zura.

New hires and promotions in the biopharma and med-tech industries, including: Alkermes, Ascensia, Caredx, Cosmos Health, Geovax, Karoo, Rivus, Seebelife, Transpire.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aktis, Alpha Tau, Alzecure, Amphastar, Haemonetics, Immedica, Intrabio, Larimar, Macrogenics, Mirus, Regeneron, Sanofi.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbvie, Biomarin, Chugai, Clinect, Epredia, Dartsbio, Five Discovery, Grünenthal, Invivyd, Microtransponder, Mindpeak, Miradx, Novartis, Novo Nordisk, Oncolytics, Pfizer, PHC, Porosome, Renew, Roche, Sarepta, Sciwind, Si-Bone, Smith+Nephew, Valinor.

Clinical updates for biopharma and med tech, including data readouts and publications: Abcuro, Arcus, Cadrenal, Fulcrum, Iovance, Keenova, Kyntra, Monte Rosa, Natera, Nicox, Novo Nordisk, Palvella, Protara, Quralis, Solascure, The United Laboratories, Viiv, Vir.

Biopharma and med-tech companies raising money in public or private financings, including: Abbott, Allurion, Alveus, Brainomix, Centauri, Exact Sciences, Salspera, Slate, Tandem Diabetes.